These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20151638)

  • 1. Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition.
    Zientek M; Stoner C; Ayscue R; Klug-McLeod J; Jiang Y; West M; Collins C; Ekins S
    Chem Res Toxicol; 2010 Mar; 23(3):664-76. PubMed ID: 20151638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator.
    Xu L; Chen Y; Pan Y; Skiles GL; Shou M
    Drug Metab Dispos; 2009 Dec; 37(12):2330-9. PubMed ID: 19773538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes.
    Tseng E; Eng H; Lin J; Cerny MA; Tess DA; Goosen TC; Obach RS
    Drug Metab Dispos; 2021 Oct; 49(10):947-960. PubMed ID: 34326140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate Constants.
    Eng H; Tseng E; Cerny MA; Goosen TC; Obach RS
    Drug Metab Dispos; 2020 Jun; 49(6):442-450. PubMed ID: 33811106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P450 3A4.
    Xu M; Lu Z; Wu Z; Gui M; Liu G; Tang Y; Li W
    Mol Pharm; 2023 Jan; 20(1):194-205. PubMed ID: 36458739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytochrome P450-mediated bioactivation of a compound containing the chemical scaffold, 4,5-dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide), to a chemically reactive p-chlorophenyl isocyanate intermediate in human liver microsomes.
    Chen H; Zientek M; Jalaie M; Zhang Y; Bigge C; Mutlib A
    Chem Res Toxicol; 2009 Sep; 22(9):1603-12. PubMed ID: 19697924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Assessment Using Cytochrome P450 Time-Dependent Inhibition Assays at Single Time and Concentration in the Early Stage of Drug Discovery.
    Kosaka M; Kosugi Y; Hirabayashi H
    J Pharm Sci; 2017 Sep; 106(9):2839-2846. PubMed ID: 28483425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions.
    Zetterberg C; Maltais F; Laitinen L; Liao S; Tsao H; Chakilam A; Hariparsad N
    Drug Metab Dispos; 2016 Aug; 44(8):1286-95. PubMed ID: 27298338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes.
    Yates P; Eng H; Di L; Obach RS
    Drug Metab Dispos; 2012 Dec; 40(12):2289-96. PubMed ID: 22942318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America.
    Grimm SW; Einolf HJ; Hall SD; He K; Lim HK; Ling KH; Lu C; Nomeir AA; Seibert E; Skordos KW; Tonn GR; Van Horn R; Wang RW; Wong YN; Yang TJ; Obach RS
    Drug Metab Dispos; 2009 Jul; 37(7):1355-70. PubMed ID: 19359406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes.
    Mao J; Johnson TR; Shen Z; Yamazaki S
    Drug Metab Dispos; 2013 Feb; 41(2):343-52. PubMed ID: 23129213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail.
    Lee E; Shon JC; Liu KH
    Biopharm Drug Dispos; 2016 Sep; 37(6):366-72. PubMed ID: 27323294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of solvents on the time-dependent inhibition of CYP3A4 and the biotransformation of AZD3839 in human liver microsomes and hepatocytes.
    Aasa J; Hu Y; Eklund G; Lindgren A; Baranczewski P; Malmquist J; Turek D; Bueters T
    Drug Metab Dispos; 2013 Jan; 41(1):159-69. PubMed ID: 23073735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cytochrome P450 3A4 by a pyrimidineimidazole: Evidence for complex heme interactions.
    Hutzler JM; Melton RJ; Rumsey JM; Schnute ME; Locuson CW; Wienkers LC
    Chem Res Toxicol; 2006 Dec; 19(12):1650-9. PubMed ID: 17173379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes.
    Takanohashi T; Isaka M; Ubukata K; Mihara R; Bernard BK
    Int J Toxicol; 2010 Mar; 29(2 Suppl):22S-6S. PubMed ID: 20388821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety.
    Mandal M; Mitra K; Grotz D; Lin X; Palamanda J; Kumari P; Buevich A; Caldwell JP; Chen X; Cox K; Favreau L; Hyde L; Kennedy ME; Kuvelkar R; Liu X; Mazzola RD; Parker E; Rindgen D; Sherer E; Wang H; Zhu Z; Stamford AW; Cumming JN
    J Med Chem; 2018 Dec; 61(23):10700-10708. PubMed ID: 30388368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico and in vitro inhibition of cytochrome P450 3A by synthetic stilbenoids.
    Basheer L; Schultz K; Guttman Y; Kerem Z
    Food Chem; 2017 Dec; 237():895-903. PubMed ID: 28764083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human cytochrome P450 3A4 by cholesterol.
    Shinkyo R; Guengerich FP
    J Biol Chem; 2011 May; 286(21):18426-33. PubMed ID: 21471209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time- and NADPH-dependent inhibition of cytochrome P450 3A4 by the cyclopentapeptide cilengitide: significance of the guanidine group and accompanying spectral changes.
    Bojić M; Barbero L; Dolgos H; Freisleben A; Gallemann D; Riva S; Guengerich FP
    Drug Metab Dispos; 2014 Sep; 42(9):1438-46. PubMed ID: 24985702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of time-dependent cytochrome p450 inhibition in a high-throughput, automated assay: introducing a novel area under the curve shift approach.
    Mukadam S; Tay S; Tran D; Wang L; Delarosa EM; Khojasteh SC; Halladay JS; Kenny JR
    Drug Metab Lett; 2012 Mar; 6(1):43-53. PubMed ID: 22372554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.